Transcripts

Denali Therapeutics (DNLI) earnings call transcripts

Earnings call transcripts for Denali Therapeutics Inc., with a summary, the guidance given, and what analysts pressed on.

  • Q2 2026 earnings call

    Management framed the quarter as early commercial validation of the transport-vehicle platform, with launch momentum supporting broader pipeline execution.

    Aug 06, 2026Confident0.82